Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 25, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals, Inc.
| 3K |
—
|
—
|
∞
| 3K |
Jun 21
| |||||||
Rhythm Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Crinetics Pharmaceuticals, Inc.
| 3.4K |
—
|
—
| +56.67% | 9.4K |
Jun 7
| |||||||
Amylyx Pharmaceuticals, Inc.
| 96.91K |
—
|
—
| +166.13% | 155.24K |
Apr 16
| |||||||
Amylyx Pharmaceuticals, Inc.
| 58.33K |
—
|
—
|
∞
| 58.33K |
Nov 27
| |||||||
Amylyx Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Rhythm Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Crinetics Pharmaceuticals, Inc.
| 6K |
—
|
—
|
∞
| 6K |
Jun 16
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.22K |
$45.25 | -$175,615.25 | -2.54% | 46.72K |
Mar 1
| |||||||
Crinetics Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Rhythm Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Ultragenyx Pharmaceutical Inc.
| 11.18K |
$66.62 | -$187,935.02 | +30.41% | 47.94K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.66K |
$66.30 | -$109,859.10 | -4.31% | 36.76K |
Jan 30
| |||||||
Ultragenyx Pharmaceutical Inc.
| -359.00 |
$81.14 | -$29,129.26 | -0.93% | 38.42K |
Oct 14
| |||||||
Ultragenyx Pharmaceutical Inc.
|
0
|
$77.56 | -$225,525.00 |
—
| 38.77K |
Sep 1 - Sep 2
|
Scheduled
| ||||||
Crinetics Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Rhythm Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Ultragenyx Pharmaceutical Inc.
| -364.00 |
$113.67 | -$41,375.88 | -0.93% | 38.77K |
May 6
| |||||||
Ultragenyx Pharmaceutical Inc.
|
0
|
$82.05 | -$270,450.00 |
—
| 39.14K |
Apr 15
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| 5.59K |
$138.18 | -$627,751.74 | +16.67% | 39.14K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -2.24K |
$140.36 | -$314,827.48 | -6.27% | 33.55K |
Jan 30
| |||||||
Ultragenyx Pharmaceutical Inc.
|
0
|
$97.09 | -$2,104,500.00 |
—
| 35.79K |
Jan 15
|
Scheduled
| ||||||
Rhythm Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 9
| |||||||
Rhythm Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ultragenyx Pharmaceutical Inc.
| -262.00 |
$88.00 | -$23,056.00 | -0.73% | 35.79K |
Oct 14
| |||||||
Crinetics Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 1
| |||||||
Crinetics Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ultragenyx Pharmaceutical Inc.
| -249.00 |
$66.26 | -$16,498.74 | -0.69% | 36.05K |
May 6
| |||||||
Ultragenyx Pharmaceutical Inc.
| 11.69K |
$56.08 | -$70,043.92 | +47.47% | 36.3K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.62K |
$53.23 | -$86,445.52 | -6.19% | 24.61K |
Jan 30
| |||||||
Ultragenyx Pharmaceutical Inc.
| 1.44K |
—
|
—
| +5.79% | 26.24K |
Oct 14
| |||||||
Ultragenyx Pharmaceutical Inc.
| 1.44K |
—
|
—
| +6.15% | 24.8K |
May 6
| |||||||
Ultragenyx Pharmaceutical Inc.
| 7K |
—
|
—
| +42.78% | 23.36K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.64K |
$48.85 | -$79,918.60 | -9.09% | 16.36K |
Jan 30
| |||||||
Ultragenyx Pharmaceutical Inc.
| 18K |
—
|
—
|
∞
| 18K |
Jan 30
| |||||||
Ultragenyx Pharmaceutical Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ariad Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Apr 16
| ||||||
Ariad Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Oct 4
| ||||||
Ariad Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.